Cancer Family
Neoplasm
CI-CAN-00000001Explore in graph →
Non-malignant22,961 active trials259 approved drugs4,031 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000001Explore in graph →
Clinical trials
105,853 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02004210 | A Phase 3 Trial Comparing TACE and TARE in Unilobar Advanced Hepatocellular Carcinoma | withdrawn | Phase 3 | 0 | Seoul National University HospitalOTHER | 1 | Apr 27, 2016 | clinicaltrials |
| NCT01622803 | Comparison Between Two Methods of Bilateral Stenting for Malignant Hilar Obstruction | withdrawn | Phase 3 | 0 | Samsung Medical CenterOTHER | 1 | Apr 26, 2016 | clinicaltrials |
| NCT01860742 |
| Randomized Phase III of PRRT Versus Interferon(CASTOR) |
| withdrawn |
| Phase 3 |
| 0 |
| Jules Bordet InstituteOTHER |
| 1 |
| Apr 5, 2016 |
| clinicaltrials |
| NCT01830101 | A Phase III Study of Re-Irradiation in Recurrent Glioblastoma | withdrawn | Phase 3 | 0 | AHS Cancer Control AlbertaOTHER | 1 | Mar 16, 2016 | clinicaltrials |
| NCT02260349 | Interest of Indocyanine Green in Neoplastic Prostatic Tissue | withdrawn | Phase 3 | 0 | Centre Hospitalier Universitaire de Saint EtienneOTHER | 0 | Mar 10, 2016 | clinicaltrials |
| NCT01058902 | The Effect Of Aspirin On Survival in Lung Cancer | withdrawn | Phase 3 | 0 | Liverpool Heart and Chest Hospital NHS Foundation TrustOTHER | 1 | Mar 7, 2016 | clinicaltrials |
| NCT02054559 | R-CHOP Alone vs. R-CHOP Plus Radiotherapy for Localized CD20+ DLBCL(ASPIRE) | withdrawn | Phase 3 | 0 | Asan Medical CenterOTHER | 1 | Feb 23, 2016 | clinicaltrials |
| NCT00349518 | Study of Dasatinib in Imatinib Resistant or Intolerant Subjects With Chronic or Advanced Phase CML or Philadelphia Chromosome Positive ALL | withdrawn | Phase 2 / Phase 3 | 0 | Bristol-Myers SquibbINDUSTRY | 6 | Feb 17, 2016 | clinicaltrials |
| NCT02539615 | A Trial of the ForeCYTE Breast Aspirator for Cytological Testing of Nipple Aspirate Fluid in Women 30-55 Years Old | withdrawn | Phase 3 | 0 | Atossa Therapeutics, Inc.INDUSTRY | 1 | Jan 25, 2016 | clinicaltrials |
| NCT01734863 | Post-operative Radiotherapy in Poor Responders Ewing's Sarcoma Patients | withdrawn | Phase 3 | 0 | Children's Cancer Hospital Egypt 57357OTHER | 1 | Jan 12, 2016 | clinicaltrials |
| NCT01067274 | ALFA-0703 Study in Older Patients With Acute Myeloblastic Leukemia (AML)(ALFA-0703) | withdrawn | Phase 3 | 0 | Acute Leukemia French AssociationOTHER | 1 | Dec 30, 2015 | clinicaltrials |
| NCT02511600 | Comparison of Progel Sealant to Standard of Care (SOC) for Patients Undergoing Decortication | withdrawn | Phase 3 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Dec 15, 2015 | clinicaltrials |
| NCT01998347 | Paclitaxel Liposome and Cisplatin as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer | withdrawn | Phase 3 | 0 | Shantou University Medical CollegeOTHER | 1 | Nov 20, 2015 | clinicaltrials |
| NCT00411281 | Low-Dose Cytarabine in Treating Infants With Down Syndrome and Transient Myeloproliferative Disorder | withdrawn | Phase 3 | 0 | Children's Oncology GroupNETWORK | 0 | Sep 30, 2015 | clinicaltrials |
| NCT01598584 | Mirtazapine Plus Gemcitabine Versus Gemcitabine in Metastasis Pancreatic Cancer | withdrawn | Phase 2 / Phase 3 | 0 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Sep 28, 2015 | clinicaltrials |
| NCT01422928 | Acupuncture for the Immune System in Radiation Cancer Patients | withdrawn | Phase 3 | 0 | British Columbia Cancer AgencyOTHER | 1 | May 25, 2015 | clinicaltrials |
| NCT00735241 | FOLFOX6 Plus Sir-Spheres Microspheres Plus Avastin in Patients With Nonresectable Liver Metastases From Colorectal Carcinoma(FAST) | withdrawn | Phase 2 / Phase 3 | 0 | Sirtex MedicalINDUSTRY | 1 | May 22, 2015 | clinicaltrials |
| NCT00319332 | A Comparative Study Of Iodine I 131 Tositumomab Therapeutic Regimen Versus Ibritumomab Tiuxetan Therapeutic Regimen | withdrawn | Phase 3 | 0 | GlaxoSmithKlineINDUSTRY | 1 | Apr 17, 2015 | clinicaltrials |
| NCT00891761 | A Study of IV Casopitant for the Prevention of Nausea and Vomiting Caused By Cisplatin-Based Highly Emetogenic Chemotherapy | withdrawn | Phase 3 | 0 | GlaxoSmithKlineINDUSTRY | 2 | Apr 17, 2015 | clinicaltrials |
| NCT02254915 | SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study I(SHTC-EUROPE-1) | withdrawn | Phase 3 | 0 | Medical Enterprises Europe B.V.INDUSTRY | 0 | Apr 1, 2015 | clinicaltrials |
| NCT01906112 | Role of Surgery for the Primary in Patients With Breast Cancer Stage IV. | withdrawn | Phase 3 | 0 | National Cancer Institute, ThailandOTHER_GOV | 1 | Feb 27, 2015 | clinicaltrials |
| NCT01386398 | Vorinostat With or Without Bortezomib in Treating Patients With Refractory or Recurrent Stage IIB, Stage III, or Stage IV Cutaneous T-Cell Lymphoma | withdrawn | Phase 3 | 0 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 0 | Jan 21, 2015 | clinicaltrials |
| NCT01492920 | Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy | withdrawn | Phase 3 | 0 | Gynecologic Oncology GroupNETWORK | 0 | Dec 31, 2014 | clinicaltrials |
| NCT01284205 | First Line Comparative Study of EN3348 (MCC) vs BCG in NMIBC | withdrawn | Phase 3 | 0 | Bioniche Life Sciences Inc.INDUSTRY | 1 | Aug 29, 2014 | clinicaltrials |
| NCT00874302 | Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid Symptoms | withdrawn | Phase 3 | 0 | Repros Therapeutics Inc.INDUSTRY | 2 | Jun 27, 2014 | clinicaltrials |
| NCT00907504 | Study Of The Effect Of CP-751,871 In Combination With Gemcitabine And Cisplatin In Patients With Advanced Non-Small Cell Lung Cancer(ADVIGO1017) | withdrawn | Phase 3 | 0 | PfizerINDUSTRY | 0 | Jun 17, 2014 | clinicaltrials |
| NCT01701349 | Fosbretabulin or Placebo in Combination With Carboplatin/Paclitaxel in Anaplastic Thyroid Cancer(FACT2) | withdrawn | Phase 3 | 0 | Mateon TherapeuticsINDUSTRY | 0 | May 1, 2014 | clinicaltrials |
| NCT01776892 | Collagenase and Needle Aponeurotomy: Single Modality Versus Combination Treatment for Dupuytren's Disease | withdrawn | Phase 3 | 0 | University of AlbertaOTHER | 1 | Apr 8, 2014 | clinicaltrials |
| NCT01326078 | Use of Lipid Emulsion or Nanoemulsion of Propofol on Children Undergoing Ambulatory Invasive Procedures. | withdrawn | Phase 2 / Phase 3 | 0 | Cristália Produtos Químicos Farmacêuticos Ltda.INDUSTRY | 0 | Mar 26, 2014 | clinicaltrials |
| NCT01169129 | Surgery and Whole Brain Radiotherapy (RT) Versus Whole Brain Radiotherapy (RT) and Radiosurgery for 1-3 Resectable Brain Metastases | withdrawn | Phase 3 | 0 | Barretos Cancer HospitalOTHER | 1 | Feb 4, 2014 | clinicaltrials |
| NCT00922129 | Effectiveness of Conversion to Sirolimus Versus Calcineurin Inhibitor (CNI) Reduction in Renal Transplant Patients With Prostate Cancer | withdrawn | Phase 2 / Phase 3 | 0 | St. Joseph's Healthcare HamiltonOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT01355783 | A Phase 3 Trial of E7777 in Combination With CHOP Compared With CHOP Alone for the First-Line Treatment of Peripheral T-cell Lymphoma | withdrawn | Phase 3 | 0 | Eisai Inc.INDUSTRY | 1 | Nov 18, 2013 | clinicaltrials |
| NCT00301886 | S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone | withdrawn | Phase 3 | 0 | SWOG Cancer Research NetworkNETWORK | 0 | Nov 13, 2013 | clinicaltrials |
| NCT00943709 | Intensive Glycemic Control on Infectious Morbidity In Patients With Acute Leukemia | withdrawn | Phase 3 | 0 | University of Medicine and Dentistry of New JerseyOTHER | 1 | Aug 30, 2013 | clinicaltrials |
| NCT00026468 | Exisulind in Preventing Polyps in Patients With Familial Adenomatous Polyposis | withdrawn | Phase 2 / Phase 3 | 0 | University of UtahOTHER | 0 | Jul 24, 2013 | clinicaltrials |
| NCT00054392 | Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer | withdrawn | Phase 3 | 0 | Fox Chase Cancer CenterOTHER | 1 | Jul 11, 2013 | clinicaltrials |
| NCT00334867 | Combination Chemotherapy With or Without Topotecan in Treating Patients With Newly Diagnosed Localized Ewing's Sarcoma | withdrawn | Phase 3 | 0 | Children's Oncology GroupNETWORK | 0 | Jun 28, 2013 | clinicaltrials |
| NCT00238160 | Surgery With or Without Hepatic Arterial Chemotherapy in Treating Patients With Liver Cancer | withdrawn | Phase 3 | 0 | Kyoto UniversityOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00447356 | High-Dose Interferon Alfa in Treating Patients With Stage II or StageIII Melanoma | withdrawn | Phase 3 | 0 | Hackensack Meridian HealthOTHER | 1 | May 13, 2013 | clinicaltrials |
| NCT00055887 | Chemotherapy and Radiation Therapy With or Without Efaproxiral in Treating Patients With Stage III Non-Small Cell Lung Cancer | withdrawn | Phase 3 | 0 | Spectrum Pharmaceuticals, IncINDUSTRY | 4 | May 10, 2013 | clinicaltrials |
| NCT00043212 | Study of a Drug [DCVax (tm)-Prostate] to Treat Prostate Cancer When Hormone Therapy is no Longer Effective. | withdrawn | Phase 3 | 0 | Northwest BiotherapeuticsINDUSTRY | 1 | May 1, 2013 | clinicaltrials |
| NCT00258466 | Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer | withdrawn | Phase 3 | 0 | Barbara Ann Karmanos Cancer InstituteOTHER | 0 | Apr 8, 2013 | clinicaltrials |
| NCT00253617 | Stent Placement With or Without Photodynamic Therapy Using Porfimer Sodium as Palliative Treatment in Treating Patients With Stage III or Stage IV Cholangiocarcinoma That Cannot Be Removed By Surgery | withdrawn | Phase 3 | 0 | Jonsson Comprehensive Cancer CenterOTHER | 2 | Apr 4, 2013 | clinicaltrials |
| NCT01786538 | Second-line FOLFOX With or Without Regorafenib in mCRC Patients Failed to First-line Irinotecan Plus Fluoropyrimidines | withdrawn | Phase 3 | 0 | Asan Medical CenterOTHER | 1 | Mar 13, 2013 | clinicaltrials |
| NCT01553123 | Efficacy and Safety Study of Ulipristal Acetate in Females With Anemia Associated With Uterine Leiomyoma | withdrawn | Phase 3 | 0 | Watson PharmaceuticalsINDUSTRY | 1 | Feb 7, 2013 | clinicaltrials |
| NCT00090675 | Maintenance ZD1839 (IRESSA®) Following Completion of Front Line, Platinum-Based, Double Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer(IMAC/Herbst) | withdrawn | Phase 3 | 0 | AstraZenecaINDUSTRY | 0 | Jan 29, 2013 | clinicaltrials |
| NCT01266811 | A Phase 3 Study of Siltuximab or Placebo in Combination With Velcade and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma | withdrawn | Phase 3 | 0 | Centocor, Inc.INDUSTRY | 14 | Jan 28, 2013 | clinicaltrials |
| NCT00324714 | Risedronate in Improving Bone Mineral Density and Bone Health in Postmenopausal Women With Ductal Carcinoma In Situ Enrolled in Clinical Trial CRUK-IBIS-II-DCIS | withdrawn | Phase 3 | 0 | ETOP IBCSG Partners FoundationNETWORK | 1 | Nov 29, 2012 | clinicaltrials |
| NCT00851162 | Using Mesenchymal Stem Cells to Fill Bone Void Defects in Patients With Benign Bone Lesions | withdrawn | Phase 2 / Phase 3 | 0 | Emory UniversityOTHER | 1 | Nov 28, 2012 | clinicaltrials |
Data updated 22 days agoSource updated Apr 27, 2016source: clinicaltrials